Estrogen receptor α and aromatase polymorphisms affect risk, prognosis, and therapeutic outcome in men with castration-resistant prostate cancer treated with docetaxel-based therapy
about
Association of estrogen receptor α PvuII and XbaI polymorphisms with prostate cancer susceptibility and risk stratification: a meta-analysis from case-control studiesAndrogen receptor genotypes predict response to endocrine treatment in breast cancer patients.Genetic susceptibility factors on genes involved in the steroid hormone biosynthesis pathway and progesterone receptor for gastric cancer risk.ESR1 Gene Polymorphisms and Prostate Cancer Risk: A HuGE Review and Meta-AnalysisThe influence of ESR1 rs9340799 and ESR2 rs1256049 polymorphisms on prostate cancer risk.Involvement of estrogen receptors in prostatic diseases.Comprehensive assessment of the association between estrogen receptor of alpha polymorphisms and the risk of prostate cancer: evidence from a meta-analysis.The association between estrogen receptor alpha polymorphisms and the risk of prostate cancer in Slovak population.Association between estrogen receptor alpha PvuII polymorphism and prostate cancer risk.Estrogen receptor alpha gene polymorphisms and risk of prostate cancer: a meta-analysis involving 18 studies.PvuII (rs2234693 T>C) polymorphism and cancer susceptibility: Evidence from 80 studies
P2860
Q33878996-762F20E0-21DB-42B7-B47D-B251E7BB083DQ34228066-0BE5DA86-ACC6-4897-BD5A-D8DC640CD5DDQ34460484-8AE066FE-FC7E-4B3F-9FF8-06D9AB860A0EQ34785620-B45C0488-28DF-4BD7-ACAA-7A4CB93326A5Q35173735-D83F575D-11EC-4897-B2A9-97A8C9E2430EQ37989170-2D52DE48-7551-4EDF-B416-E7C4335C93A8Q47095480-827251C6-2865-4E92-BC22-72BC918B9719Q50936603-FF08BD82-6852-4BAB-935B-937CC3386885Q53134069-0E03D0C2-A574-4BB8-AA01-3231081AD245Q53137702-CF72FBA1-01EA-4087-BEA1-D3191153D8D1Q57174165-54646B35-ABDA-49DB-8B5F-3D8C3DD571F6
P2860
Estrogen receptor α and aromatase polymorphisms affect risk, prognosis, and therapeutic outcome in men with castration-resistant prostate cancer treated with docetaxel-based therapy
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Estrogen receptor α and aromat ...... d with docetaxel-based therapy
@ast
Estrogen receptor α and aromat ...... d with docetaxel-based therapy
@en
Estrogen receptor α and aromat ...... d with docetaxel-based therapy
@nl
type
label
Estrogen receptor α and aromat ...... d with docetaxel-based therapy
@ast
Estrogen receptor α and aromat ...... d with docetaxel-based therapy
@en
Estrogen receptor α and aromat ...... d with docetaxel-based therapy
@nl
prefLabel
Estrogen receptor α and aromat ...... d with docetaxel-based therapy
@ast
Estrogen receptor α and aromat ...... d with docetaxel-based therapy
@en
Estrogen receptor α and aromat ...... d with docetaxel-based therapy
@nl
P2093
P2860
P356
P1476
Estrogen receptor α and aromat ...... d with docetaxel-based therapy
@en
P2093
C Tyler Kirkland
Caitlin E Baum
David Venzon
Douglas K Price
Erica V Stein
Romano Danesi
Sandra B Ockers
Tristan M Sissung
William D Figg
P2860
P304
P356
10.1210/JC.2010-2070
P407
P577
2010-11-24T00:00:00Z